Discover a recent study that has examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Struggling with hair loss? Whether it's due to menopause, postpartum changes, or stress, the right supplements can make a ...

Keranique's Hair Regrowth Treatment is getting rave reviews from Amazon shoppers who swear it helped fill in bald patches after years of hair loss.

Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and Mice Feb. 20, 2024 — The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and ...

If you struggle with hair loss, you probably have come up with a hundred possible reasons that could be causing it: from hormonal changes to using the wrong products or medical conditions like a ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Showcase your company news with guaranteed exposure both in print and online 25 years ago, Denver's economy thrived on IT, real estate & oil. DBJ will kick… Be Inspired! Meet Your Mentor! Make ...

More than 90 people on a Royal Caribbean cruise ship returning to Tampa are sick after a gastrointestinal illness outbreak.